Table 5 Predictors of annual direct medical costs for patients with ischaemic and haemorrhagic stroke attending two major hospitals in Cameroon, 2013–2017
Ischaemic stroke | |||
Variable | Univariate models β (95% CI) | Model 1 β (95% CI) | Model 2 β (95% CI) |
Age, per year increase | 0.008 (0.002, 0.014)* | 0.007 (0.001, 0.014)* | 0.003 (−0.002, 0.008) |
Sex (Reference: Female) | |||
Male | −0.124 (− 0.283, 0.034) | −0.095 (− 0.254, 0.064) | −0.077 (− 0.201, 0.048) |
History of hypertension (Reference: No) | |||
Yes | −0.142 (− 0.332, 0.048) | −0.175 (− 0.364, 0.014) | −0.143 (− 0.295, 0.009) |
History of diabetes (Reference: No) | |||
Yes | 0.203 (0.033, 0.373)* | 0.209 (0.040, 0.378)* | 0.188 (0.052, 0.324)* |
History of atrial fibrillation (Reference: No) | |||
Yes | 0.096 (−0.136, 0.328) | 0.052 (−0.179, 0.284) | − 0.074 (− 0.256, 0.109) |
History of CVD event (Reference: No) | |||
Yes | 0.048 (−0.126, 0.222) | 0.026 (− 0.149, 0.202) | 0.023 (− 0.113, 0.160) |
Intercept | 12.128 (11.775, 12.481)** | ||
Haemorrhagic stroke | |||
Variable | Univariate models β (95% CI) | Model 1 β (95% CI) | Model 2 β (95% CI) |
Age, per year increase | −0.004 (−0.012, 0.005) | −0.003 (− 0.012, 0.006) | 0.001 (− 0.006, 0.009) |
Sex (Reference: Female) | |||
Male | 0.088 (−0.130, 0.305) | 0.070 (− 0.154, 0.293) | 0.042 (− 0.155, 0.238) |
History of hypertension (Reference: No) | |||
Yes | 0.315 (0.057, 0.687)* | 0.316 (0.059, 0.692)* | −0.230 (− 0.560, 0.100) |
History of diabetes (Reference: No) | |||
Yes | 0.227 (−0.023, 0.477) | 0.249 (−0.004, 0.502) | 0.140 (− 0.088, 0.368) |
History of atrial fibrillation (Reference: No) | |||
Yes | 0.201 (−0.425, 0.828) | 0.216 (−0.419, 0.851) | − 0.062 (− 0.647, 0.523) |
History of CVD event (Reference: No) | |||
Yes | −0.063 (− 0.318, 0.192) | −0.070 (− 0.326, 0.187) | 0.098 (− 0.138, 0.333) |
Intercept | 12.575 (11.935, 13.214)** | ||